Histogenics has completed >50% of the required enrollment in its ongoing NeoCart® Phase III clinical trial in the treatment of knee cartilage defects.
Bone Therapeutics extended its collaboration with Kasios to combine ALLOB® bone cell therapy with a 3D-printed synthetic cage intended to support the spinal fusion process.
Seikagaku and Kaken Pharmaceutical will discontinue development of SI-657, an additional indication of enthesopathy for the ARTZ injectable joint function-improving agent.Â
BONESUPPORT expanded its 2014 injectable bone substitute registry to include 230 CERAMENTâ„¢ G procedures, as well as procedures involving the CERAMENT V formulation.Â
Exactech acquired Exactech Australia, an independent importer and distributor of Exactech’s orthopaedic implants, instrumentation and surgical technology.
Study results from 5-year follow-up demonstrate the long-term, sustained therapeutic effect of Paradigm Spine’s coflex® Interlaminar Stabilization® vs. fusion in the treatment of lumbar spinal stenosis.